Clinical Trials Logo

Clinical Trial Summary

Continuous positive airway pressure (CPAP) became the established treatment for overlap syndrome (OS). It has been showed that the survival benefits of CPAP favored hypercapnic patients. When considering hypercapnic stable COPD patients, survival benefits occurred when the use of bi- level ventilation therapy was targeted to significantly reduce hypercapnia.

This highlights the relevance of hypercapnia and hypoventilation correction. Thus, the purpose of this study is to compare the use of CPAP to Bi-level ventilation in hypercapnic OS patients, since the later may correct not only the airway patency but also increase the magnitude of each breath.


Clinical Trial Description

Obstructive sleep apnea syndrome (OSAS) and chronic obstructive pulmonary disease (COPD) represent two of the most prevalent respiratory disorders in clinical practice and their coexistence is often described has "overlap syndrome" (OS) In patients with COPD, the coexistence of OSA is associated with an increased risk of death from any cause, and hospitalization because of COPD exacerbation. Treatment with continuous positive airway pressure (CPAP) has been showed to be effective and associated with improved survival and decreased hospitalizations. When CPAP became established treatment for overlap syndrome, a multivariate analysis revealed that the hours of CPAP use were an independent predictor of mortality. Furthermore, it has been showed that the survival benefit of CPAP favors hypercapnic patients with overlap syndrome.

Regarding hypercapnic stable COPD patients, the best results with long-term non-invasive positive pressure ventilation have been noted in studies using more intensive strategies of ventilation, with higher inspiratory pressures and higher backup rates that improved or even normalized daytime hypercapnia. In fact, survival benefits occurred when ventilation was targeted to significantly reduce hypercapnia.

As for typical COPD, overlap syndrome patients might also benefit from optimal daytime hypercapnia correction, which could be better achieved using bi-level ventilation instead of CPAP, since it could not only maintain airway patency but also improve alveolar ventilation.

This study aims to compare CPAP therapy to bi-level ventilatory support in overlap syndrome patients, not only for the efficacy to achieve hypercapnia reduction, but also regarding acute disease exacerbations, symptoms and treatment compliance. Therefore, the authors designed a randomized controlled trial with recruitment and power calculations based on the applicant's own data.

After the diagnosis, patients will be randomized either for CPAP or BPAP treatment.

If CPAP is to be initiated, optimal pressure to maintain upper airway patency will be determined. If there are continued obstructive respiratory events at 15 cm H2O of CPAP, patients will cross-over to the BPAP study arm.

Regarding BPAP titration, patients will be treated with ventilators set in pressure support spontaneous/timed mode, both inspiratory and expiratory positive airway pressures (IPAP and EPAP) will be manually titrated. EPAP will ensure optimal pressure for maintaining upper airway patency and IPAP will be defined according to patient tolerance and pressure support necessary to achieve normal PaCO2 values or to reduce baseline PaCO2 by 20% or more; Follow-up will be performed at 1, 6 and 12 months. Follow-up will include clinical evaluation with physical examination and questionnaires (COPD Assessment test, Epworth Sleepiness Scale and MRC dyspnea score), blood gas analysis, treatment adherence, AHI, nocturnal pulse oximetry and exacerbations.

12-month follow-up will also include lung function test, 6-min walking test and nocturnal capnography. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03766542
Study type Interventional
Source Hospital Sao Joao
Contact
Status Not yet recruiting
Phase N/A
Start date January 1, 2019
Completion date September 1, 2020

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04711200 - LYell SYndrome MEsenchymal Stromal Cells Treatment Phase 1/Phase 2
Completed NCT02244957 - Right Ventricular Hemodynamics Using Cardiac MRI in Patients COPD and OSA N/A
Not yet recruiting NCT05958563 - Impact of Continuous Positive Airway Pressure on the Occurrence of Acute Exacerbations of COPD in Patients With COPD-OSA Overlap Syndrome (CO-OS) N/A
Not yet recruiting NCT05190458 - Evaluation of High Velocity Nasal Insufflation in Management of Respiratory Failure in Patients With Overlap Syndrome N/A
Active, not recruiting NCT02488590 - Systematic Approach for the Diagnosis and Treatment of Obstructive Lung Diseases
Enrolling by invitation NCT05740306 - Irritable Bowel Syndrome Overlaping Celiac Disease
Completed NCT03069976 - "Overlap Syndrome and PSC: Evaluating Role of Gut Microflora and Its Identification With Antibiotics in Children" N/A
Recruiting NCT03569826 - Canadian Network for Autoimmune Liver Disease
Recruiting NCT02363413 - Initiation of Non- Invasive Ventilation at Home Versus Hospital Among Patients With Overlap Syndrome N/A
Recruiting NCT05237505 - The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome) Phase 2
Not yet recruiting NCT01427673 - Continuous Positive Airway Pressure Versus Noninvasive Ventilation in Patients With Overlap Syndrome Phase 3
Recruiting NCT06377332 - Biomarkers of Dementia in Chronic Sleep and Breathing Disorders
Recruiting NCT04179981 - Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome) N/A
Completed NCT01523197 - Auto-trilevel Ventilator for Patients With Overlap Syndrome N/A